PEBP1 and gastrointestinal stromal tumor: Since higher RKIP expression was associated with increased survival probability and can serve as a reliable predictor of NIH risk grades, clinical interventions could utilize RKIP levels as a biomarker to predict the overall survival rate of GIST patients.